| Literature DB >> 32328530 |
Yoojin Choi1, Ji Hyeon Hwang1, Sang Yup Lee1.
Abstract
Rapid, sensitive, selective, convenient, and cost-effective pathogen diagnosis is important to prevent further spread of pandemic diseases, minimize social and economic losses, and to facilitate right clinical therapy. Over the past few years, various sensor-based diagnostic systems outperforming conventional pathogenic diagnostic assays have been developed. Among them, colorimetric biosensors detecting target molecules by the naked eye have attracted much attention due to their simplicity, practicality, and cost-effectiveness. Recently, nanomaterials have been adopted as a versatile signal transduction and amplification tool for rapid and sensitive detection of pathogenic bacteria and viruses. Here, recent trends and advances are reviewed in detecting and diagnosing pathogenic bacteria and viruses using colorimetric biosensors employing various nanomaterials. In addition, it is discussed how nanomaterials and bioreceptors can be better integrated together to develop rapid and sensitive colorimetric detection system in the future.Entities:
Keywords: bacteria; colorimetric biosensors; nanomaterials; pathogens; viruses
Year: 2018 PMID: 32328530 PMCID: PMC7169612 DOI: 10.1002/smtd.201700351
Source DB: PubMed Journal: Small Methods ISSN: 2366-9608
Summary of recent studies on colorimetric detection of pathogenic bacteria and viruses using various NMs
| Colorimetric strategy | Target pathogen | Nanomaterials | Functionalized biomolecules | Assay time | Detection limit | Reference |
|---|---|---|---|---|---|---|
| Oxidation by peroxidase‐like NMs |
| Pt‐coated Fe3O4 NP | Antibody | 30 min | 10 CFU |
|
|
| Fe3O4 NP | DNA aptamers | 10 min | 7.5 × 105 CFU mL−1 |
| |
| Influenza A (H1N1) virus | Au NP | Antibody | 1 min | 10.79 pg mL−1 |
| |
| Influenza A (H3N2) virus | Au NP | Antibody | 1 min | 11.62 PFU |
| |
| Influenza A (H3N2) virus | CNT | Antibody | 10 min | 3.4 PFU mL−1 |
| |
| Norovirus | Graphene‐Au nanohybrid | Antibody | 10 min | 92.7 pg mL−1 |
| |
| Aggregation of NMs |
| Ag, Au NP | Citrate ions | 20 min | 0.05 OD600
|
|
|
| Ag, Au NP | Citrate ions | 20 min | 0.05 OD600 in 200 µL |
| |
|
| Ag, Au NP | Citrate ions | 20 min | 0.05 OD600 in 200 µL |
| |
|
| Au NP | Protein | – | 4.5 × 103 CFU mL−1 |
| |
| CRPA (carbapenem‐resistant | Ag, Au NP | Citrate ions | 20 min | 0.05 OD600 in 200 µL |
| |
|
| Au NP | Protein | 10 min | 8 CFUs mL−1 |
| |
|
| Ag, Au NP | Citrate ions | 20 min | 0.05 OD600 in 200 µL |
| |
|
| Au NP | Antibody | 4 h | 3 ± 1 bacteria mL−1 |
| |
|
| Au NP | Antibody | 1 min | 105 CFU mL−1 |
| |
|
| Au NP | Antibody | 4 h | 3 ± 1 bacteria mL−1 |
| |
|
| Au NP | DNA | 30 min | 1 pmol of synthetic DNA |
| |
|
| Au NP | DNA | 30 min | 1 pmol of synthetic DNA |
| |
|
| Ag, Au NP | Citrate ions | 20 min | 0.05 OD600 in 200 µL |
| |
|
| Au NP | Protein | 10 min | 8 CFUs mL−1 for |
| |
|
| Au NP | Antibody | 4 h | 3 ± 1 bacteria mL−1 |
| |
|
| Au NP | DNA aptamer | – | 56 CFU mL−1 |
| |
|
| Ag, Au NP | Citrate ions | 20 min | 0.05 OD600 in 200 µL |
| |
|
| Au NP | Antibody | 1 min | 120 CFU mL−1 |
| |
| Cyprinid herpesvirus‐3 (CyHV‐3) | Au NP | DNA | 20 min | 10 fg CyHV‐3‐Au NP DNA (30 virions) |
| |
| Human papillomavirus | Ag NP | PNA | – | 1.03 × 10−9
|
| |
| Influenza A (H1N1) virus | Au NP | Antibody | 20 min | 7.6 HAU |
| |
| Influenza A (H3N2) virus | Au NP | Antibody | 20 min | 7.6 HAU |
| |
| Influenza A (H1N1) virus | Glycan‐functionalized Au NP | Antibody | 90 min | 8 HA |
| |
| Influenza A (H5N1) virus | Glycan‐functionalized Au NP | Antibody | 90 min | 8 HA |
| |
| Middle East respiratory syndrome coronavirus | Ag NP | PNA | – | 1.53 × 10−9
|
| |
| Mycobacterium tuberculosis | Ag NP | PNA | – | 1.27 × 10−9
|
| |
| Destabilization of NMs |
| PDA | Lysine | 48 h | 1–10 CFU mL−1 |
|
| Influenza A (H1N1) virus | PEP‐PDA | Peptide | 5 min | 105 PFU |
|
NP: nanoparticle
CFU: colony‐forming units
PFU: plaque‐forming units
CNT: carbon nanotube
OD600: optical density at a wavelength of 600 nm
PNA: peptide nucleic acid
HAU: hemagglutinin units per 50 µL
HA: hemagglutinin
PDA: polydiacetylene
PEP‐PDA: peptide‐functionalized PDA.
Figure 1Schematic illustration of colorimetric detection based on oxidation by peroxidase‐like NMs. A) Scheme of oxidizing peroxidase substrates by various peroxidase‐like NMs. B) Schematic to detect S. typhimurium using aptamer‐adsorbed MNPs. C) Detection of influenza (H3N2) virus using a nanohybrid of CNTs and Au NPs, and norovirus‐like particles in human serum using a nanohybrid of graphene and Au NPs. MNP: magnetic nanoparticle; TMB: 3,3′,5,5′‐tetramethyl‐benzidine; ABTS: 2,2′‐azino‐bis(3‐ethylbenzothiazoline‐6‐sulfonic acid); CNT: carbon nanotube. The contents of (B) and (C) are described in refs. 49, 56, 57 and they are redrawn here.
Figure 2Schematic illustration of colorimetric detection based on aggregation of NMs. A) Scheme of aggregation of NPs with various biomolecular functionalization. B) Signal‐amplified detection of E. coli, S. typhimurium, and L. monocytogenes using cysteine‐containing nanoliposomes (redrawn from ref. 63). C) Schematic to detect the Cy‐HV3 DNA using aggregation of citrate‐stabilized Au NP in the presence of dsDNA (redrawn from ref. 67). D) Schematic to detect Middle East respiratory syndrome coronavirus DNA using redispersion of Ag NP in the presence of dsDNA (redrawn from ref. 70). PNA: peptide nucleic acid; IgG: immunoglobulin G; PBS: phosphate buffer saline; Cy‐HV3: Cyprinid herpesvirus‐3; ssDNA: single‐stranded DNA; acpc PNA: (2S)‐aminocyclopentane‐(1S)‐carboxylic acid pyrrolidinyl PNA.
Figure 3Schematic illustration of colorimetric detection based on destabilization of NM structure. A) Scheme of a color transition of PDA vesicles by their structure change on target binding. B) Scheme of detecting influenza H1N1 virus with PEP–PDA vesicle system (redrawn from ref. 76), and detecting Salmonella choleraesuis with PDA/SPH/CHO/lysine vesicle system (strategy described in ref. 77). PCDA: 10,12‐pentacosadyionic acid; PDA: polydiacetylene; polydiacetylene; PEP: HA1‐specific peptide; SPH: sphingomyelin; CHO: cholesterol.